Home › Funds › Bellevue Group AG › ANRO
Bellevue Group AG position in ANRO
ALTO NEUROSCIENCE INC · Health Care
Bellevue Group AG reported holding 1,163,588 shares of ANRO (ALTO NEUROSCIENCE INC) in its Q3 2026 13F filing — a position valued at US$29.7M, representing 0.62% of its reported portfolio and ranking #42 among its reported holdings. Bellevue Group AG first reported this position in Q3 2026.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Bellevue Group AG's ANRO position evolved
Bellevue Group AG first disclosed a stake in ANRO in Q3 2026 at 1,163,588 shares (US$29.7M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2026 | 1.16M | $29.71M | New |
About ANRO and 13F data
ANRO (ALTO NEUROSCIENCE INC) is a Health Care company. 60 other funds we track also report a position in ANRO — the largest reported positions include Alpha Wave Global, LP (US$94.7M), Commodore Capital LP (US$69.5M), EcoR1 Capital, LLC (US$57.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ANRO
- Alpha Wave Global, LP 3.71M sh · $94.66M · Q3 2026
- Commodore Capital LP 2.72M sh · $69.52M · Q3 2026
- EcoR1 Capital, LLC 2.23M sh · $56.98M · Q3 2026
- PERCEPTIVE ADVISORS LLC 1.76M sh · $44.96M · Q3 2026
- Spruce Street Capital LP 1.68M sh · $42.80M · Q3 2026
- Vivo Capital, LLC 1.36M sh · $34.72M · Q3 2026
- Parkman Healthcare Partners LLC 948.86K sh · $24.22M · Q3 2026
- 72 Investment Holdings, LLC 667.78K sh · $17.05M · Q3 2026
- Affinity Asset Advisors, LLC 643.34K sh · $16.42M · Q3 2026
- Saturn V Capital Management LP 518.11K sh · $13.23M · Q3 2026
- Integral Health Asset Management, LLC 500.00K sh · $12.77M · Q3 2026
- Venrock Adviser, LLC 500.00K sh · $12.77M · Q3 2026
More on Bellevue Group AG
FAQ
How long has Bellevue Group AG held ANRO?
Bellevue Group AG has disclosed ANRO holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is Bellevue Group AG's current position in ANRO?
As of Q3 2026, Bellevue Group AG holds 1.16M shares of ANRO (ALTO NEUROSCIENCE INC), valued at $29.71M, representing 0.62% of its reported portfolio and ranking #42.
Has Bellevue Group AG been buying or selling ANRO?
In the latest 13F filing (Q3 2026), Bellevue Group AG newly opened its position in ANRO.
Which other funds hold ANRO?
Other major institutional holders of ANRO include Alpha Wave Global, LP, Commodore Capital LP, EcoR1 Capital, LLC, among 60 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.